These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661 [TBL] [Abstract][Full Text] [Related]
5. Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications. Hu XC; Wong IH; Chow LW Oncol Rep; 2003; 10(6):1811-5. PubMed ID: 14534701 [TBL] [Abstract][Full Text] [Related]
6. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer. Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA. Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512 [TBL] [Abstract][Full Text] [Related]
9. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. Kang GH; Lee S; Lee HJ; Hwang KS J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506 [TBL] [Abstract][Full Text] [Related]
10. Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Parrella P; Poeta ML; Gallo AP; Prencipe M; Scintu M; Apicella A; Rossiello R; Liguoro G; Seripa D; Gravina C; Rabitti C; Rinaldi M; Nicol T; Tommasi S; Paradiso A; Schittulli F; Altomare V; Fazio VM Clin Cancer Res; 2004 Aug; 10(16):5349-54. PubMed ID: 15328171 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Magdinier F; Ribieras S; Lenoir GM; Frappart L; Dante R Oncogene; 1998 Dec; 17(24):3169-76. PubMed ID: 9872332 [TBL] [Abstract][Full Text] [Related]
12. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis. Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343 [TBL] [Abstract][Full Text] [Related]
13. CpG methylation of the ERalpha and ERbeta genes in breast cancer. Kim SJ; Kim TW; Lee SY; Park SJ; Kim HS; Chung KW; Lee ES; Kang HS Int J Mol Med; 2004 Aug; 14(2):289-93. PubMed ID: 15254780 [TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation profile of ovarian epithelial neoplasms. Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849 [TBL] [Abstract][Full Text] [Related]
15. Hierarchical clustering of lung cancer cell lines using DNA methylation markers. Virmani AK; Tsou JA; Siegmund KD; Shen LY; Long TI; Laird PW; Gazdar AF; Laird-Offringa IA Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):291-7. PubMed ID: 11895880 [TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999 [TBL] [Abstract][Full Text] [Related]
17. Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array. Radpour R; Kohler C; Haghighi MM; Fan AX; Holzgreve W; Zhong XY Oncogene; 2009 Aug; 28(33):2969-78. PubMed ID: 19503099 [TBL] [Abstract][Full Text] [Related]
18. DNA hypermethylation in breast cancer and its association with clinicopathological features. Li S; Rong M; Iacopetta B Cancer Lett; 2006 Jun; 237(2):272-80. PubMed ID: 16029926 [TBL] [Abstract][Full Text] [Related]
19. Detection of gene promoter hypermethylation in fine needle washings from breast lesions. Jerónimo C; Costa I; Martins MC; Monteiro P; Lisboa S; Palmeira C; Henrique R; Teixeira MR; Lopes C Clin Cancer Res; 2003 Aug; 9(9):3413-7. PubMed ID: 12960130 [TBL] [Abstract][Full Text] [Related]
20. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]